<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02544776</url>
  </required_header>
  <id_info>
    <org_study_id>effect of amlodipine in pco</org_study_id>
    <nct_id>NCT02544776</nct_id>
  </id_info>
  <brief_title>Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients</brief_title>
  <official_title>Effect of Amlodipine and Clomid on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahmed Fathy Ali Mohamed Ghanem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the basis of the current study, amlodipine seems to be a promising drug on improving
      uterine, ovarian blood flow, size of pre-ovulatory follicle, midluteal progesterone level and
      pregnancy outcome in patients with pco.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To know if amlodipine has vasodilator effect on ovarian ar. In pco patient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in ovarian artery perfusion</measure>
    <time_frame>day number five and day number 9 of menstrual cycle</time_frame>
    <description>peak systolic velocity ( psv ) measured by doppler u/s</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of mature follicle</measure>
    <time_frame>day 14 of menstrual cycle</time_frame>
    <description>by vaginal u/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endometrial thickening</measure>
    <time_frame>day number five and day number 9 of menstrual cycle</time_frame>
    <description>by vaginal u/s</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Female Infertility Associated With Anovulation</condition>
  <arm_group>
    <arm_group_label>Clomifene citrate and Amlodipine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amlodipine 5mg tablet and Clomifene citrate 50 mg tablet once by mouth daily at morning starting from day number 5 of menstrual cycle till day number 9.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clomifene citrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clomifene citrate 50mg and once daily at morning starting from day number 5 of menstrual cycle till day number 9</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomifene citrate ( clomid 50 mg )</intervention_name>
    <arm_group_label>Clomifene citrate and Amlodipine</arm_group_label>
    <arm_group_label>Clomifene citrate</arm_group_label>
    <other_name>clomid ( 50 mg )</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amlodipine</intervention_name>
    <arm_group_label>Clomifene citrate and Amlodipine</arm_group_label>
    <other_name>Norvasc 5mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Demographic features including females in age of ≥20 &amp; ≤35, and BMI of ≤39.

          -  Infertility secondary to polycystic ovary , The choice of polycystic ovary patients
             will be according to the Rotterdam consensus workshop (Rotterdam, 2004), and the
             diagnosis of polycystic ovary by ultrasonography will be made according to Adams et
             al. criteria which are the most often cited (Adams et al., 1985).The Rotterdam
             criteria as follows:

               -  Oligo- or anovulation.

               -  Clinical and/or biochemical signs of hyper androgynism

               -  The presence of polycystic ovaries on ultrasound scan. Ultrasound findings of
                  enlarged ovaries with multiple small cysts (10-12 or more of 2-9 mm in diameter)
                  scattered around the periphery and highly echogenic stroma

        Exclusion Criteria:

          -  Including other causes of infertility diagnosed during infertility work up.

          -  Patients refused to participate or to continue study.

          -  Also, hepatic, cardiac, and hypotensive patients will be excluded from the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2015</study_first_submitted>
  <study_first_submitted_qc>September 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2015</study_first_posted>
  <last_update_submitted>March 24, 2016</last_update_submitted>
  <last_update_submitted_qc>March 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Ahmed Fathy Ali Mohamed Ghanem</investigator_full_name>
    <investigator_title>Resident of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>pco</keyword>
  <keyword>Amlodipine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Anovulation</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amlodipine</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

